The Company will hold a conference call and an online presentation on the same day at
The dial-in numbers for the conference call are:
SE: +46 850558354
US: +1 8332498406
The presentation will be webcasted and can be accessed from the following weblink:
https://tv.streamfabriken.com/bonesupport-q3-2021
For more information contact:
BONESUPPORTHOLDINGAB
Emil Billbäck, CEO
+46 (0) 46 286 53 70
Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se www.cordcom.se
About BONESUPPORT(TM)
BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient's own bone and have the capability of eluting drugs. BONESUPPORT's bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in
BONESUPPORT and CERAMENT are registered trademarks of
https://news.cision.com/bonesupport-holding-ab/r/bonesupport-holding-ab--publ----interim-report-q3-2021-invitation-to-conference-call-and-webcast,c3435122
https://mb.cision.com/Main/16090/3435122/1482383.pdf
(c) 2021 Cision. All rights reserved., source